$ECL

Green Eric Mark purchased $1.0M of ECL

Green Eric Mark purchased 3,690 shares of ECOLAB INC. (ECL) at an average of $276.64 ($276.58–$277.29, $1.02M total) across 2 trades on 2026-09-11.

Original reporting
SEC EDGAR · Green Eric Mark
Published Sep 14, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECL
Bullish
medium confidence
Mentioned
$ECL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECLBullishMed
01

Why it matters

The $1M purchase adds to the director's holdings, indicating personal confidence in ECL's prospects.

02

Market read

Insider buying can influence short-term sentiment; traders may consider a modest long position.

03

What to watch

The purchase size is modest relative to total shares outstanding; market may not react significantly.

Relevance 7/10Novelty 8/10Timing: after market close filing

Background

Form 4 filings disclose insider transactions; director purchases are monitored for potential signals.

Company-level read

Ticker impact

$ECLBullishMedium confidence
Context

Director Green Eric Mark bought 3,690 shares of Ecolab for $1.02M, increasing his stake to 7,947 shares.

Expected impact

Potential modest price uptick as market absorbs insider buying.

Evidence & confidence

A $1M purchase by a director is material for a mid-cap stock and may influence sentiment, though the stake remains small relative to float.

Market effects

May be viewed positively for the water treatment and hygiene sector as insider confidence.

Limited to US markets where ECL trades.

Low global impact beyond ECL investors.

Counterpoint

Insider buying could be a routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Ecolab Inc.

    Provider of water, hygiene and infection control solutions.

  • Green Eric Mark

    Director of Ecolab who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECLMedAI 8/10

Ecolab Inc (ECL) (Q3 2026) Earnings Call Highlights: 7% Organic Sales Growth, 63%

Ecolab Inc (ECL) reported 7% organic sales growth in Q3 2026, with High-Tech segment growing 63%. Challenges include North American restaurant traffic decline, commodity cost inflation, and a 1% growth headwind from the Middle East. CoolIT acquisition is expected to impact EPS. CEO Christophe Beck reaffirmed 2027 margin targets and growth expectations, citing strong demand in High-Tech and Life Sciences.

$ECLMed

Ecolab (ECL) Q3 2026 Earnings Call Transcript

Ecolab (ECL) reported Q3 2026 pro forma sales growth of high single digits and adjusted EPS growth of mid-teens. The company highlighted strong performance in Food & Beverage, Life Sciences, and Global High-Tech, with organic sales growth of 8%, 17%, and 63% respectively. Ecolab also emphasized its One Ecolab model, which integrates water, hygiene, and digital solutions to drive customer value and growth. The company plans to expand field sales and service offerings to accelerate growth further.

$ECLMedAI 8/10

Ecolab Q3 Earnings Call Highlights

Ecolab (ECL) reported Q3 growth in Life Sciences (17%), Ecolab Digital (34%), and Pest Elimination (8%). Global High-Tech saw 63% growth, driven by data-center cooling and water systems. Ecolab expects 2027 organic sales growth at the upper end of its 5%-7% target range and adjusted operating-income margin of 20%. The company is integrating recent acquisitions and reducing leverage.

$ECLHighAI 8/10

Ecolab Q3 2026 slides: organic growth accelerates to 7%, margins expand

Ecolab (ECL) reported Q3 2026 results with 7% organic sales growth, 13% total sales growth, and adjusted EPS of $2.18, slightly above estimates. Revenue was $4.69B, below consensus. Stock rose 1.29% premarket. High-growth segments like Global High-Tech and Life Sciences drove performance. Management expects full-year EPS of $8.10-$8.20 and 2027 margin target of 20%.

$ECLMedAI 8/10

Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y

Ecolab reported Q3 2026 adjusted earnings of $2.18 per share, up 5% Y/Y, matching estimates. Revenues rose 13% to $4.69B, beating estimates. Organic sales increased 7%, with strong demand in Global High-Tech and Life Sciences. ECL raised its 2026 adjusted earnings outlook to $8.10-$8.20 per share, citing acquisitions and pricing gains.